{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:43:54Z","timestamp":1790189034279,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547"],"award-info":[{"award-number":["82170547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04200-7","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:13:54Z","timestamp":1754583234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The value of fecal calprotectin measured by fluorescent immunochromatography assay in evaluating clinical and endoscopic activity in ulcerative colitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Mingyang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"10080","key":"4200_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(16)32126-2.","journal-title":"Lancet"},{"issue":"6","key":"4200_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749\u201353. https:\/\/doi.org\/10.1136\/gut.2005.082909.","journal-title":"Gut"},{"issue":"Suppl 3","key":"4200_CR3","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1\u2013106. https:\/\/doi.org\/10.1136\/gutjnl-2019-318484.","journal-title":"Gut"},{"issue":"5","key":"4200_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","volume":"149","author":"BE Sands","year":"2015","unstructured":"Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149(5):1275\u2013e12852. https:\/\/doi.org\/10.1053\/j.gastro.2015.07.003.","journal-title":"Gastroenterology"},{"issue":"5","key":"4200_CR5","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/med.21893","volume":"42","author":"D Liu","year":"2022","unstructured":"Liu D, Saikam V, Skrada KA, et al. Inflammatory bowel disease biomarkers. Med Res Rev. 2022;42(5):1856\u201387. https:\/\/doi.org\/10.1002\/med.21893.","journal-title":"Med Res Rev"},{"issue":"3","key":"4200_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007IF","volume":"164","author":"S Singh","year":"2023","unstructured":"Singh S, Ananthakrishnan AN, Nguyen NH, et al. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology. 2023;164(3):344\u201372. https:\/\/doi.org\/10.1053\/j.gastro.2022.12.007IF. 25.1 B1.","journal-title":"Gastroenterology"},{"issue":"4","key":"4200_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.MIB.0000442681.85545.31","volume":"20","author":"U Kopylov","year":"2014","unstructured":"Kopylov U, Rosenfeld G, Bressler B, et al. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(4):742\u201356. https:\/\/doi.org\/10.1097\/01.MIB.0000442681.85545.31.","journal-title":"Inflamm Bowel Dis"},{"key":"4200_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/bs.acc.2018.07.005","volume":"87","author":"RM Ayling","year":"2018","unstructured":"Ayling RM, Kok K. Fecal calprotectin. Adv Clin Chem. 2018;87:161\u201390. https:\/\/doi.org\/10.1016\/bs.acc.2018.07.005.","journal-title":"Adv Clin Chem"},{"issue":"6","key":"4200_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R, et al. Third European Evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, Extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649\u201370. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008.","journal-title":"J Crohns Colitis"},{"issue":"10","key":"4200_CR10","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","volume":"70","author":"A Jukic","year":"2021","unstructured":"Jukic A, Bakiri L, Wagner EF, et al. Calprotectin: from biomarker to biological function. Gut. 2021;70(10):1978\u201388. https:\/\/doi.org\/10.1136\/gutjnl-2021-324855.","journal-title":"Gut"},{"issue":"6","key":"4200_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","volume":"12","author":"MR Konikoff","year":"2006","unstructured":"Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(6):524\u201334. https:\/\/doi.org\/10.1097\/00054725-200606000-00013.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"4200_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","volume":"56","author":"A Ricciuto","year":"2019","unstructured":"Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019;56(5):307\u201320. https:\/\/doi.org\/10.1080\/10408363.2019.1619159.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"12","key":"4200_CR13","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/ibd.22917","volume":"18","author":"G D\u2019Haens","year":"2012","unstructured":"D\u2019Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2218\u201324. https:\/\/doi.org\/10.1002\/ibd.22917.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"4200_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/2050640613518201","volume":"2","author":"D Labaere","year":"2014","unstructured":"Labaere D, Smismans A, Van Olmen A, et al. Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease. United Eur Gastroenterol J. 2014;2(1):30\u20137. https:\/\/doi.org\/10.1177\/2050640613518201.","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"4200_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ueg2.12069","volume":"9","author":"F D\u2019Amico","year":"2021","unstructured":"D\u2019Amico F, Rubin DT, Kotze PG, et al. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United Eur Gastroenterol J. 2021;9(4):451\u201360. https:\/\/doi.org\/10.1002\/ueg2.12069.","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"4200_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","volume":"132","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132(2):763\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2006.12.038.","journal-title":"Gastroenterology"},{"issue":"8","key":"4200_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ecco-jcc\/jjv077","volume":"9","author":"SP Travis","year":"2015","unstructured":"Travis SP, Schnell D, Feagan BG, et al. The impact of clinical information on the assessment of endoscopic activity: characteristics of the ulcerative colitis endoscopic index of severity [UCEIS]. J Crohns Colitis. 2015;9(8):607\u201316. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv077.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"4200_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jju012","volume":"9","author":"E Louis","year":"2015","unstructured":"Louis E. Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practice. J Crohns Colitis. 2015;9(1):1\u20133. https:\/\/doi.org\/10.1093\/ecco-jcc\/jju012.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"4200_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ecco-jcc\/jjz107","volume":"14","author":"L Hart","year":"2020","unstructured":"Hart L, Chavannes M, Kherad O, et al. Faecal calprotectin predicts endoscopic and histological activity in clinically quiescent ulcerative colitis. J Crohns Colitis. 2020;14(1):46\u201352. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz107.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"4200_CR20","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031.","journal-title":"Gastroenterology"},{"issue":"11","key":"4200_CR21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/ecco-jcc\/jjw104","volume":"10","author":"M Arai","year":"2016","unstructured":"Arai M, Naganuma M, Sugimoto S, et al. The ulcerative colitis endoscopic index of severity is useful to predict Medium- to Long-Term prognosis in ulcerative colitis patients with clinical remission. J Crohns Colitis. 2016;10(11):1303\u20139. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw104.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"4200_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/ecco-jcc\/jjaa093","volume":"15","author":"F D\u2019Amico","year":"2021","unstructured":"D\u2019Amico F, Nancey S, Danese S, et al. A practical guide for faecal calprotectin measurement: Myths and realities. J Crohns Colitis. 2021;15(1):152\u201361. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa093.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"4200_CR23","doi-asserted-by":"publisher","first-page":"e23059","DOI":"10.1002\/jcla.23059","volume":"34","author":"R Li","year":"2020","unstructured":"Li R, Zhao X, Dong J, et al. Evaluation of a fluorescent immunochromatography test for fecal calprotectin. J Clin Lab Anal. 2020;34(2):e23059. https:\/\/doi.org\/10.1002\/jcla.23059.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"4200_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.crohns.2014.06.002","volume":"9","author":"A Lasson","year":"2015","unstructured":"Lasson A, Stotzer PO, \u00d6hman L, et al. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J Crohns Colitis. 2015;9(1):26\u201332. https:\/\/doi.org\/10.1016\/j.crohns.2014.06.002.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04200-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:02:05Z","timestamp":1754629325000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04200-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4200"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04200-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Approval Number: 20220827). It was confirmed that informed consent was obtained from all subjects and\/or their legal guardian(s), who were also informed of the potential research use of clinical data. All methods were performed in accordance with the relevant guidelines and regulations, including compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"566"}}